What is the first-line treatment for COPD?

The first-line treatment for Chronic Obstructive Pulmonary Disease (COPD) is short-acting beta-agonists (SABAs). These medications are primarily used for their rapid bronchodilator effects, which help relieve acute symptoms of bronchospasm and improve airflow in patients experiencing exacerbations of their COPD. SABAs such as albuterol are effective in quickly alleviating symptoms, which is particularly important during acute episodes of breathlessness or wheezing.

In the management of COPD, short-acting beta-agonists are typically utilized as a rescue medication, allowing patients to have immediate relief from symptoms. This is crucial for improving patient quality of life and enabling them to engage in daily activities without the impediment of breathlessness.

While long-acting beta-agonists and anticholinergics are also important in the management of COPD, they are not considered first-line for immediate symptom relief like SABAs. Long-acting beta-agonists provide more sustained control of symptoms, while anticholinergics can also lead to improved lung function and symptom relief over time. Corticosteroids, on the other hand, are generally reserved for patients with more severe disease or acute exacerbations and are not the primary treatment choice for ongoing management in